Insider trade

Officer sold ~$71K of HIMS shares in the open market

Traded Feb 27, 2026 · Filed Mar 2, 2026

Why it stands out

Hims & Hers Health's Chief Legal Officer sold $71K of Hims & Hers Health shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$25K–$100KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$70,742

Shares × reported transaction price

Timing vs results

4 days after results of Feb 23, 2026, 73 days before results of May 11, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+48.4%	−0.5%	+48.8%
30 days	+21.0%	−3.6%	+24.6%
90 days	+75.5%	+11.5%	+64.0%
180 days	+87.0%	+12.8%	+74.2%

Past results only. Not a forecast.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2025 by the Reporting Person.

7mo ago

Derivative exercise or conversion — not an open-market buy.

Scheduled in advance7mo ago

7mo ago

Derivative exercise or conversion — not an open-market buy.